Hoth Therapeutics, Inc.

NasdaqCM:HOTH Stock Report

Market Cap: US$5.8m

Hoth Therapeutics Dividends and Buybacks

Dividend criteria checks 0/6

Hoth Therapeutics does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-63.5%

Buyback Yield

Total Shareholder Yield-63.5%
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Hoth Therapeutics partners with Altasciences to manufacture HT-TBI for brain injury

Sep 20

Hoth Therapeutics granted grace days by Nasdaq to regain compliance with bid price rule

Jun 29

Here's Why We're Watching Hoth Therapeutics' (NASDAQ:HOTH) Cash Burn Situation

Nov 12
Here's Why We're Watching Hoth Therapeutics' (NASDAQ:HOTH) Cash Burn Situation

Hoth Therapeutics extends agreement for experimental antibiotic

Jun 18

We're Not Very Worried About Hoth Therapeutics' (NASDAQ:HOTH) Cash Burn Rate

Jun 10
We're Not Very Worried About Hoth Therapeutics' (NASDAQ:HOTH) Cash Burn Rate

Hoth Therapeutics expands research agreement with VCU for COVID-19 therapeutic

May 05

Hoth Therapeutics shares rise 10% on developmental plans for HT-KIT in multiple orphan diseases and rare cancers

May 03

Hoth provides pipeline and regulatory timeline update

Feb 02

FDA grants Hoth Therapeutics Pre-IND meeting for HT-001, shares up 15%

Jan 13

Hoth Therapeutics to initiate IND enabling studies of HT-001 in cancer

Jan 11

Hoth Therapeutics inks deal for treatment of multi-drug resistant bacterial lung infections, shares up 15%

Jan 04

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if HOTH's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if HOTH's dividend payments have been increasing.


Dividend Yield vs Market

Hoth Therapeutics Dividend Yield vs Market
How does HOTH dividend yield compare to the market?
SegmentDividend Yield
Company (HOTH)n/a
Market Bottom 25% (US)1.3%
Market Top 25% (US)4.2%
Industry Average (Pharmaceuticals)2.4%
Analyst forecast (HOTH) (up to 3 years)n/a

Notable Dividend: Unable to evaluate HOTH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate HOTH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate HOTH's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as HOTH has not reported any payouts.


Discover strong dividend paying companies